Literature DB >> 9312026

An alternative pathway for gene regulation by Myc.

K Peukert1, P Staller, A Schneider, G Carmichael, F Hänel, M Eilers.   

Abstract

The c-Myc protein activates transcription as part of a heteromeric complex with Max. However, Myc-transformed cells are characterized by loss of expression of several genes, suggesting that Myc may also repress gene expression. Two-hybrid cloning identifies a novel POZ domain Zn finger protein (Miz-1; Myc-interacting Zn finger protein-1) that specifically interacts with Myc, but not with Max or USF. Miz-1 binds to start sites of the adenovirus major late and cyclin D1 promoters and activates transcription from both promoters. Miz-1 has a potent growth arrest function. Binding of Myc to Miz-1 requires the helix-loop-helix domain of Myc and a short amphipathic helix located in the carboxy-terminus of Miz-1. Expression of Myc inhibits transactivation, overcomes Miz-1-induced growth arrest and renders Miz-1 insoluble in vivo. These processes depend on Myc and Miz-1 association and on the integrity of the POZ domain of Miz-1, suggesting that Myc binding activates a latent inhibitory function of this domain. Fusion of a nuclear localization signal induces efficient nuclear transport of Miz-1 and impairs the ability of Myc to overcome transcriptional activation and growth arrest by Miz-1. Our data suggest a model for how gene repression by Myc may occur in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9312026      PMCID: PMC1170199          DOI: 10.1093/emboj/16.18.5672

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  47 in total

1.  Transcriptional suppression of cellular gene expression by c-Myc.

Authors:  B S Yang; T J Geddes; R J Pogulis; B de Crombrugghe; S O Freytag
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

2.  Reciprocal regulation of adipogenesis by Myc and C/EBP alpha.

Authors:  S O Freytag; T J Geddes
Journal:  Science       Date:  1992-04-17       Impact factor: 47.728

3.  Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/Max heterodimers.

Authors:  S J Berberich; M D Cole
Journal:  Genes Dev       Date:  1992-02       Impact factor: 11.361

4.  Sequence-specific DNA binding by the c-Myc protein.

Authors:  T K Blackwell; L Kretzner; E M Blackwood; R N Eisenman; H Weintraub
Journal:  Science       Date:  1990-11-23       Impact factor: 47.728

5.  Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation.

Authors:  G C Prendergast; D Lawe; E B Ziff
Journal:  Cell       Date:  1991-05-03       Impact factor: 41.582

6.  Myc and Max proteins possess distinct transcriptional activities.

Authors:  L Kretzner; E M Blackwood; R N Eisenman
Journal:  Nature       Date:  1992-10-01       Impact factor: 49.962

7.  IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc.

Authors:  H Shibuya; M Yoneyama; J Ninomiya-Tsuji; K Matsumoto; T Taniguchi
Journal:  Cell       Date:  1992-07-10       Impact factor: 41.582

8.  Ornithine decarboxylase activity is critical for cell transformation.

Authors:  M Auvinen; A Paasinen; L C Andersson; E Hölttä
Journal:  Nature       Date:  1992-11-26       Impact factor: 49.962

9.  Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region.

Authors:  G C Prendergast; E B Ziff
Journal:  Science       Date:  1991-01-11       Impact factor: 47.728

10.  Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites.

Authors:  A S Zervos; J Gyuris; R Brent
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

View more
  120 in total

Review 1.  The Max network gone mad.

Authors:  T A Baudino; J L Cleveland
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

2.  Cyclin E-mediated elimination of p27 requires its interaction with the nuclear pore-associated protein mNPAP60.

Authors:  D Müller; K Thieke; A Bürgin; A Dickmanns; M Eilers
Journal:  EMBO J       Date:  2000-05-15       Impact factor: 11.598

Review 3.  Burkitt's lymphoma: new insights into molecular pathogenesis.

Authors:  C Bellan; S Lazzi; G De Falco; A Nyongo; A Giordano; L Leoncini
Journal:  J Clin Pathol       Date:  2003-03       Impact factor: 3.411

4.  Mad4 is regulated by a transcriptional repressor complex that contains Miz-1 and c-Myc.

Authors:  Louise Kime; Stephanie C Wright
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

5.  The p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides.

Authors:  Juliet M Daniel; Christopher M Spring; Howard C Crawford; Albert B Reynolds; Akeel Baig
Journal:  Nucleic Acids Res       Date:  2002-07-01       Impact factor: 16.971

6.  E3 ubiquitin ligase Mule ubiquitinates Miz1 and is required for TNFalpha-induced JNK activation.

Authors:  Yi Yang; HanhChi Do; Xuejun Tian; Chaozheng Zhang; Xinyuan Liu; Laura A Dada; Jacob I Sznajder; Jing Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

7.  Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes.

Authors:  C Cinti; L Leoncini; A Nyongo; F Ferrari; S Lazzi; C Bellan; R Vatti; A Zamparelli; G Cevenini; G M Tosi; P P Claudio; N M Maraldi; P Tosi; A Giordano
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

8.  Miz1 Controls Schwann Cell Proliferation via H3K36me2 Demethylase Kdm8 to Prevent Peripheral Nerve Demyelination.

Authors:  David Fuhrmann; Marco Mernberger; Andrea Nist; Thorsten Stiewe; Hans-Peter Elsässer
Journal:  J Neurosci       Date:  2017-12-07       Impact factor: 6.167

9.  Regulation of the cyclin-dependent kinase inhibitor 1A gene (CDKN1A) by the repressor BOZF1 through inhibition of p53 acetylation and transcription factor Sp1 binding.

Authors:  Min-Kyeong Kim; Bu-Nam Jeon; Dong-In Koh; Kyung-Sup Kim; So-Yoon Park; Chae-Ok Yun; Man-Wook Hur
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

10.  Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification.

Authors:  Linda J Valentijn; Jan Koster; Franciska Haneveld; Rachida Ait Aissa; Peter van Sluis; Marloes E C Broekmans; Jan J Molenaar; Johan van Nes; Rogier Versteeg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.